DK1727620T3 - C1 symmetriske biphosphinlegander og deres anvendelse i asymmetrisk syntese af pregabilin - Google Patents
C1 symmetriske biphosphinlegander og deres anvendelse i asymmetrisk syntese af pregabilinInfo
- Publication number
- DK1727620T3 DK1727620T3 DK05708733T DK05708733T DK1727620T3 DK 1727620 T3 DK1727620 T3 DK 1727620T3 DK 05708733 T DK05708733 T DK 05708733T DK 05708733 T DK05708733 T DK 05708733T DK 1727620 T3 DK1727620 T3 DK 1727620T3
- Authority
- DK
- Denmark
- Prior art keywords
- pregabiline
- symmetric
- asymmetric synthesis
- biphosphine ligands
- biphosphine
- Prior art date
Links
- 238000011914 asymmetric synthesis Methods 0.000 title 1
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B53/00—Asymmetric syntheses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/30—Preparation of optical isomers
- C07C227/32—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/16—Preparation of optical isomers
- C07C231/18—Preparation of optical isomers by stereospecific synthesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5027—Polyphosphines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/5045—Complexes or chelates of phosphines with metallic compounds or metals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
- C07F9/5329—Polyphosphine oxides or thioxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5463—Compounds of the type "quasi-phosphonium", e.g. (C)a-P-(Y)b wherein a+b=4, b>=1 and Y=heteroatom, generally N or O
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
- B01J2231/60—Reduction reactions, e.g. hydrogenation
- B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
- B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
- B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/822—Rhodium
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Catalysts (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55258604P | 2004-03-12 | 2004-03-12 | |
US58651204P | 2004-07-09 | 2004-07-09 | |
PCT/IB2005/000642 WO2005087370A1 (en) | 2004-03-12 | 2005-03-09 | C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1727620T3 true DK1727620T3 (da) | 2007-12-03 |
Family
ID=34961258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05708733T DK1727620T3 (da) | 2004-03-12 | 2005-03-09 | C1 symmetriske biphosphinlegander og deres anvendelse i asymmetrisk syntese af pregabilin |
Country Status (21)
Country | Link |
---|---|
US (2) | US20050228190A1 (da) |
EP (1) | EP1727620B1 (da) |
JP (1) | JP2007528893A (da) |
KR (2) | KR100823758B1 (da) |
AR (1) | AR051533A1 (da) |
AT (1) | ATE371496T1 (da) |
AU (1) | AU2005221401A1 (da) |
BR (1) | BRPI0508615A (da) |
CA (1) | CA2559086A1 (da) |
CY (1) | CY1106877T1 (da) |
DE (1) | DE602005002253T2 (da) |
DK (1) | DK1727620T3 (da) |
ES (1) | ES2292107T3 (da) |
IL (1) | IL177482A0 (da) |
NO (1) | NO20063574L (da) |
NZ (1) | NZ549004A (da) |
PL (1) | PL1727620T3 (da) |
PT (1) | PT1727620E (da) |
RU (1) | RU2335342C2 (da) |
TW (1) | TWI299990B (da) |
WO (1) | WO2005087370A1 (da) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL126999A (en) | 1996-07-24 | 2002-03-10 | Warner Lambert Co | Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain |
WO2006108151A1 (en) | 2005-04-06 | 2006-10-12 | Teva Pharmaceutical Industries Ltd. | Crystalline forms of pregabalin |
US7488846B2 (en) * | 2005-04-11 | 2009-02-10 | Teva Pharmaceuical Industries Ltd. | Pregabalin free of lactam and a process for preparation thereof |
EP1768950A2 (en) * | 2005-04-11 | 2007-04-04 | Teva Pharmaceutical Industries Ltd. | Process for making (s)-pregabalin |
MX2007000525A (es) | 2005-05-10 | 2007-03-28 | Teva Pharma | Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella. |
ATE486841T1 (de) * | 2005-05-10 | 2010-11-15 | Teva Pharma | Verfahren zur herstellung von pregabalin und salzen daraus |
KR20070118305A (ko) * | 2005-05-10 | 2007-12-14 | 테바 파마슈티컬 인더스트리즈 리미티드 | 3-카르바모일메틸-5-메틸 헥산산의 광학 분할 |
KR20080034205A (ko) * | 2005-09-19 | 2008-04-18 | 테바 파마슈티컬 인더스트리즈 리미티드 | (s)-프레가발린의 신규한 합성을 위한 주요 중간체인 키랄3-카르바모일메틸-5-메틸 헥산산 |
CA2646474A1 (en) * | 2006-04-24 | 2007-11-08 | Teva Pharmaceutical Industries Ltd. | Processes for the synthesis of 3-isobutylglutaric acid |
WO2007139933A2 (en) * | 2006-05-24 | 2007-12-06 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof |
EP1912931A2 (en) * | 2006-05-31 | 2008-04-23 | Teva Pharmaceutical Industries Ltd. | Preparation of (s)-pregabalin-nitrile |
KR20080036060A (ko) * | 2006-05-31 | 2008-04-24 | 테바 파마슈티컬 인더스트리즈 리미티드 | 프레가발린의 중간체의 제조에 효소 분할을 이용하는 방법 |
GB0700622D0 (en) * | 2007-01-12 | 2007-02-21 | Johnson Matthey Plc | Process for preparing cationic rhodium complexes |
TW200846308A (en) * | 2007-03-22 | 2008-12-01 | Teva Pharma | Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid |
KR20090101462A (ko) * | 2007-10-03 | 2009-09-28 | 테바 파마슈티컬 인더스트리즈 리미티드 | 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법 |
KR20110025917A (ko) | 2008-05-21 | 2011-03-14 | 산도즈 아게 | 5-메틸-3-니트로메틸-헥산산 에스테르의 입체선택적 효소 가수분해 방법 |
WO2009158343A1 (en) * | 2008-06-23 | 2009-12-30 | Teva Pharmaceutical Industries, Ltd. | Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester |
GB0812290D0 (en) * | 2008-07-04 | 2008-08-13 | Johnson Matthey Plc | Process for preparing cationic rhodium complexes |
WO2011056737A1 (en) | 2009-11-05 | 2011-05-12 | Boehringer Ingelheim International Gmbh | Novel chiral phosphorus ligands |
CN102781948A (zh) | 2010-02-12 | 2012-11-14 | 埃南蒂亚有限公司 | 作为用于制备不对称合成的催化剂的配体的对映异构地富集的氨基二膦 |
GB201103092D0 (en) * | 2011-02-23 | 2011-04-06 | Univ Dublin | Process |
WO2016075082A1 (en) | 2014-11-10 | 2016-05-19 | Sandoz Ag | Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam |
US10196413B2 (en) | 2016-12-06 | 2019-02-05 | Boehringer Ingelheim International Gmbh | Chiral dihydrobenzoazaphosphole ligands and synthesis thereof |
JP2020500937A (ja) | 2016-12-06 | 2020-01-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規キラルジヒドロベンゾオキサホスホール配位子及びその合成 |
JP6949903B2 (ja) | 2019-06-24 | 2021-10-13 | 日本化学工業株式会社 | 光学活性ビスホスフィノメタン及びその製造方法、並びに遷移金属錯体及び不斉触媒 |
CN111647020A (zh) * | 2020-04-09 | 2020-09-11 | 宁波赜军医药科技有限公司 | 一种膦氧双齿配体的合成方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
US5616793A (en) * | 1995-06-02 | 1997-04-01 | Warner-Lambert Company | Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
US5637767A (en) * | 1995-06-07 | 1997-06-10 | Warner-Lambert Company | Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid |
IL126999A (en) * | 1996-07-24 | 2002-03-10 | Warner Lambert Co | Pharmaceutical preparations containing isobutylgaba and its history for use in the treatment of pain |
US6329429B1 (en) * | 1997-06-25 | 2001-12-11 | Warner-Lambert Company | Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases |
AU9019198A (en) * | 1997-08-19 | 1999-03-08 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants |
US6127418A (en) * | 1997-08-20 | 2000-10-03 | Warner-Lambert Company | GABA analogs to prevent and treat gastrointestinal damage |
AU8668598A (en) * | 1997-08-20 | 1999-03-08 | University Of Oklahoma, The | Gaba analogs to prevent and treat gastrointestinal damage |
US6306910B1 (en) * | 1998-07-09 | 2001-10-23 | Warner-Lambert Company | Use of Gaba-analogues for treating insomnia |
NZ508490A (en) * | 1998-07-09 | 2003-08-29 | Warner Lambert Co | Use of a combination of a GABA analog and caffeine as an analgesic |
EP1121114B1 (en) * | 1998-10-16 | 2007-01-10 | Warner-Lambert Company Llc | Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders |
AU777046B2 (en) * | 2000-01-27 | 2004-09-30 | Warner-Lambert Company Llc | Asymmetric synthesis of pregabalin |
MXPA02001147A (es) * | 2001-03-19 | 2004-04-21 | Warner Lambert Co | Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica. |
US6696058B2 (en) * | 2002-01-29 | 2004-02-24 | Laclede, Inc. | Aqueous enzymatic denture adhesives |
NI200300043A (es) * | 2002-03-28 | 2003-11-05 | Warner Lambert Co | AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA. |
-
2005
- 2005-03-09 PT PT05708733T patent/PT1727620E/pt unknown
- 2005-03-09 WO PCT/IB2005/000642 patent/WO2005087370A1/en active IP Right Grant
- 2005-03-09 EP EP05708733A patent/EP1727620B1/en active Active
- 2005-03-09 ES ES05708733T patent/ES2292107T3/es active Active
- 2005-03-09 AU AU2005221401A patent/AU2005221401A1/en not_active Abandoned
- 2005-03-09 CA CA002559086A patent/CA2559086A1/en not_active Abandoned
- 2005-03-09 KR KR1020077014949A patent/KR100823758B1/ko not_active IP Right Cessation
- 2005-03-09 RU RU2006132505/04A patent/RU2335342C2/ru not_active IP Right Cessation
- 2005-03-09 DK DK05708733T patent/DK1727620T3/da active
- 2005-03-09 BR BRPI0508615-9A patent/BRPI0508615A/pt not_active IP Right Cessation
- 2005-03-09 DE DE602005002253T patent/DE602005002253T2/de not_active Expired - Fee Related
- 2005-03-09 NZ NZ549004A patent/NZ549004A/en unknown
- 2005-03-09 AT AT05708733T patent/ATE371496T1/de not_active IP Right Cessation
- 2005-03-09 PL PL05708733T patent/PL1727620T3/pl unknown
- 2005-03-09 JP JP2007502434A patent/JP2007528893A/ja not_active Withdrawn
- 2005-03-09 KR KR1020067018522A patent/KR100847922B1/ko not_active IP Right Cessation
- 2005-03-10 AR ARP050100918A patent/AR051533A1/es active IP Right Grant
- 2005-03-10 TW TW094107381A patent/TWI299990B/zh active
- 2005-03-11 US US11/078,228 patent/US20050228190A1/en not_active Abandoned
-
2006
- 2006-08-07 NO NO20063574A patent/NO20063574L/no not_active Application Discontinuation
- 2006-08-14 IL IL177482A patent/IL177482A0/en unknown
-
2007
- 2007-09-17 CY CY20071101203T patent/CY1106877T1/el unknown
-
2009
- 2009-01-14 US US12/353,450 patent/US20090124820A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR100847922B1 (ko) | 2008-07-22 |
EP1727620B1 (en) | 2007-08-29 |
DE602005002253T2 (de) | 2008-05-29 |
PT1727620E (pt) | 2007-11-05 |
AR051533A1 (es) | 2007-01-24 |
JP2007528893A (ja) | 2007-10-18 |
PL1727620T3 (pl) | 2007-12-31 |
BRPI0508615A (pt) | 2007-07-31 |
KR20060118603A (ko) | 2006-11-23 |
EP1727620A1 (en) | 2006-12-06 |
RU2006132505A (ru) | 2008-03-27 |
US20090124820A1 (en) | 2009-05-14 |
AU2005221401A1 (en) | 2005-09-22 |
WO2005087370A1 (en) | 2005-09-22 |
TW200600090A (en) | 2006-01-01 |
TWI299990B (en) | 2008-08-21 |
ES2292107T3 (es) | 2008-03-01 |
KR20070074671A (ko) | 2007-07-12 |
KR100823758B1 (ko) | 2008-04-21 |
US20050228190A1 (en) | 2005-10-13 |
RU2335342C2 (ru) | 2008-10-10 |
ATE371496T1 (de) | 2007-09-15 |
NO20063574L (no) | 2006-09-05 |
DE602005002253D1 (de) | 2007-10-11 |
CY1106877T1 (el) | 2012-09-26 |
NZ549004A (en) | 2009-04-30 |
IL177482A0 (en) | 2006-12-10 |
CA2559086A1 (en) | 2005-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1727620T3 (da) | C1 symmetriske biphosphinlegander og deres anvendelse i asymmetrisk syntese af pregabilin | |
DK1954140T3 (da) | Glycerollevulinatketaler og deres anvendelse | |
DK1928886T3 (da) | Pyridin-derivater og deres anvendelse i behandlingen af psykotiske lidelser | |
DK1992697T3 (da) | Fremstilling af TNFR-Fc | |
DK1743076T3 (da) | Akustiske elementer og fremstilling af disse | |
DK2056845T3 (da) | Struktur og anvendelse af 5'-phosphat-oligonukleotider | |
DK1747290T3 (da) | Anvendelse af fuldblod i PCR reaktioner | |
ATE455629T1 (de) | Rasierer und kassetten | |
ATE542648T1 (de) | Rasierer und kassetten | |
IS8305A (is) | Bindandi smíðar og aðferðir við notkun þeirra | |
DK3176254T3 (da) | Anvendelse af fedtvæv-afledte stromale stamceller i behandling af fistel | |
DK2342233T3 (da) | Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer | |
DE602005011803D1 (de) | Kombinationen aus antimuscarinischen mitteln und corticosteroiden | |
DK1917246T3 (da) | Benzoquinazolinderivater og deres anvendelse til behandling af knoglesygdomme | |
DK1727567T3 (da) | Aptamer-terapeutiske midler nyttige i behandling af komplementrelaterede forstyrrelser | |
DK1737971T3 (da) | Blandinger af bindingsproteiner | |
DK3385267T3 (da) | Syntese af boronestere og syreforbindelser | |
DK3321359T3 (da) | Variante former af uratoxidase og anvendelse deraf | |
DK3556866T3 (da) | Mutationer af pik3ca-genet i humane cancere | |
DE602006004463D1 (de) | Kristallform von asenapinmaleat | |
DK1765376T3 (da) | Topiske sammensætninger og anvendelse deraf til behandling af epitel-relaterede tilstande | |
DE602005007987D1 (de) | achtelung und -entschachtelung | |
DK2152654T3 (da) | 4-chlor-4-alkoxy-1,1,1-trifluor-2-butanoner, fremstilling heraf og deres anvendelse ved fremstilling af 4-alkoxy-1,1,1-trifluor-3-buten-2-oner | |
ATE524183T1 (de) | Verwendung von sanglifehrin bei der hcv-therapie | |
DK1931377T3 (da) | CD4+ T epitoper af survivin og deres anvendelse |